Articles From: Gilead Sciences Announces 43 Cents Quarterly Dividend Program and $15 Billion Share Buyback Program to Gladstone Capital Corporation Invests in Electronic Manufacturing Services Company


2015/2/3
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the company’s Board of Directors has authorized a dividend program under which the company intends to pay quarterly dividends of $0.43 per share, beginning in the second quarter of 2015, subject to quarterly declarations by the Board of Directors.
Sign-up for Gilead Sciences Announces 43 Cents Quarterly Dividend Program and $15 Billion Share Buyback Program investment picks
2015/1/6
Gilead Sciences, Inc. (Nasdaq:GILD) and Phenex Pharmaceuticals AG, a privately-held biotechnology company, today announced the signing of a definitive agreement under which Gilead will acquire Phenex’s Farnesoid X Receptor (FXR) program comprising small molecule FXR agonists for the treatment of liver diseases including nonalcoholic steatohepatitis (NASH). Under the terms of the agreement, Gilead will pay Phenex an upfront payment plus additional payments based upon achievement of certain development milestones that may potentially be worth up to $470 million.
Sign-up for Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases investment picks
2015/2/3
Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2014.
Sign-up for Gilead Sciences Announces Fourth Quarter and Full Year 2014 Financial Results investment picks
2015/2/4
By Jonathan D.
Sign-up for Gilead Sciences Down on Discounting News investment picks
2015/1/12
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the 33 rd Annual J.P. Morgan Healthcare Conference in San Francisco.
Sign-up for Gilead Sciences to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 investment picks
2015/2/24
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the RBC Capital Markets 2015 Healthcare Conference in New York.
Sign-up for Gilead Sciences to Present at the RBC Capital Markets 2015 Healthcare Conference on Wednesday, February 25 investment picks
2015/2/9
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from two upcoming investor conferences: the 17 th Annual BIO CEO & Investor Conference and the 2015 Leerink Global Healthcare Conference, both taking place in New York.
Sign-up for Gilead Sciences to Present at Two Upcoming Investor Conferences investment picks
2015/1/27
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2014 financial results will be released on Tuesday, February 3, at 4:05 p.m. Eastern Time.
Sign-up for Gilead Sciences to Release Fourth Quarter and Full Year 2014 Financial Results on Tuesday, February 3, 2015 investment picks
2014/12/22
Drugmaker Gilead Sciences Inc. (GILD) recorded its largest single-session fall since its January 1992 initial public offering Monday after a pharmacy benefit manager dropped the company's Hepatitis C drug in favor of a rival's product.
Sign-up for Gilead sees largest one-day drop since IPO investment picks
2014/12/29
Gilead Sciences Inc. shares (GILD) climbed about 3% in early trade Monday and were among the top S&P 500 gainers, after Morgan Stanley upgraded the stock to overweight from equal-weight.
Sign-up for Gilead shares up 3% as Morgan Stanley upgrades to overweight investment picks
2015/1/6
Gilead Sciences Inc. (GILD) said Tuesday it is buying Phenex Pharmaceuticals AG's Farnesoid X Receptor (FXR) program, which comprises small molecule FXR agonists for the treatment of liver diseases including nonalcoholic steatohepatitis (NASH). As part of the deal, Gilead will pay the privately-held German company an upfront payment plus additional payments based on certain milestones that could be worth up to $470 million.
Sign-up for Gilead to buy liver disease treatment from Germany's Phenex investment picks
2015/2/4
By Russ Britt, MarketWatch Shares drop as investors fear high margins will come to an end LOS ANGELES (MarketWatch)--The future appeared golden when Gilead Sciences Inc. reported its results Tuesday, with earnings per share blowing past forecasts and revenue beating estimates by more than half a billion dollars.
Sign-up for Gilead to discount its pricey Sovaldi drug investment picks
2015/1/5
By Russ Britt, MarketWatch Retail giant to focus on biotech firm's $1,000-a-day pills LOS ANGELES (MarketWatch) -- Shares of Gilead Sciences Inc. were up more than 2% Monday after the biotechnology giant scored an exclusive rights deal with the nation's largest drug-store chain, CVS Health Corp., for two Hepatitis C treatments that cost $1,000 per pill or more.
Sign-up for Gilead, CVS strike deal on Hepatitis C drugs investment picks
2015/2/4
By Josh Beckerman Cigna Corp.
Sign-up for Gilead's Harvoni Selected as Cigna Preferred Treatment for Hepatitis C Genotype 1 investment picks
2015/2/4
According to a recent survey* by Gillette® [NYSE: PG], 35 percent of American men say shaving messes are a frequent cause of arguments with their significant other—more than the 28 percent who cite leaving the toilet seat up as a reason! With that in mind, Gillette has constantly strived to revolutionize the way the world shaves, and today, is continuing that commitment with the launch of the new Gillette Fusion ProGlide Sensitive 2-in-1 Shave Gel Plus Skin Care that guarantees a rust-free bathroom.
Sign-up for Gillette® to the Relationship Rescue: Introduces New ProGlide Sensitive 2-in-1 Shave Gel Plus Skin Care™ with Reimagined Formula and Rust Free Packaging Design investment picks
2014/12/11
SAN DIEGO, Calif., Dec.
Sign-up for Gilman Louie Joins Cubic Executive Advisory Board investment picks
2015/2/19
MEERSBURG, Germany and WASHINGTON, Feb.
Sign-up for GiroSolution Collaborates with UATP to Offer Airlines Additional Online Payment Methods investment picks
2015/1/29
By John Revill ZURICH--
Sign-up for Givaudan Earnings Rise But It Warns of Tough 2015 --2nd Update investment picks
2015/1/29
By John Revill ZURICH--
Sign-up for Givaudan Earnings Rise On Sweet Emerging-Market Growth--Update investment picks
2014/12/16
Chicago O’Hare International Airport is the busiest airport in the U.S., with more than five million Americans coming through the airport in December for the past several years.
Sign-up for Giving the Gift of Tech Advice: Geek Squad Arrives at Chicago O’Hare International Airport This Holiday with First-Ever ‘Pro Bono’ Precinct investment picks
2014/12/24
http://www.ccnmatthews.com/logos/20081113-gvc.gif VANCOUVER, BRITISH COLUMBIA --
Sign-up for Glacier Announces Asset Sale investment picks
2015/1/23
http://www.ccnmatthews.com/logos/20081113-gvc.gif VANCOUVER, BRITISH COLUMBIA --
Sign-up for Glacier Announces Trade Media Asset Sale investment picks
2015/1/7
KALISPELL, Mont., Jan.
Sign-up for Glacier Bancorp, Inc. Announces Fourth Quarter Earnings Release and Conference Call investment picks
2015/1/29
HIGHLIGHTS: Net income of $28.1 million for the current quarter, an increase of 6 percent from the prior year fourth quarter net income of $26.5 million.
Sign-up for Glacier Bancorp, Inc. Announces Results for the Quarter Ended December 31, 2014 investment picks
2014/12/30
KALISPELL, Mont., Dec.
Sign-up for Glacier Bancorp, Inc. Declares Special Dividend investment picks
2015/1/29
MCLEAN, Va., Jan.
Sign-up for Gladstone Capital Corporation Earnings Call and Webcast Information investment picks
2014/12/22
MCLEAN, Va., Dec.
Sign-up for Gladstone Capital Corporation Invests $8.4 Million in B+T Group investment picks
2014/12/29
MCLEAN, Va., Dec.
Sign-up for Gladstone Capital Corporation Invests in Electronic Manufacturing Services Company investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Gilead Sciences Announces 43 Cents Quarterly Dividend Program and $15 Billion Share Buyback Program to Gladstone Capital Corporation Invests in Electronic Manufacturing Services Company
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent